Three polymorphs of 3-(3-phenyl-1H-1,2,4-triazol-5-yl)-2H-1-benzopyran-2-one formed from different solvents

被引:3
作者
Shishkina, Svitlana V. [1 ,2 ,3 ]
Konovalova, Irina S. [1 ]
Trostianko, Pavlo V. [2 ]
Geleverya, Anna O. [2 ]
Kovalenko, Sergiy M. [2 ,3 ]
Bunyatyan, Natalya D. [3 ,4 ]
机构
[1] NAS Ukraine, SSI Inst Single Crystals, 60 Nauky Ave, UA-61001 Kharkov, Ukraine
[2] Kharkov Natl Univ, 4 Svobody Sq, UA-61077 Kharkov, Ukraine
[3] IM Sechenov First Moscow State Med Univ, Fed State Autonomous Educ Inst Higher Educ, 8 Trubeckaya, Moscow 119991, Russia
[4] Sci Ctr Expert Evaluat Med Prod, Fed State Budgetary Inst, Petrovsky Blvd 8,Bldg 2, Moscow 127051, Russia
来源
ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY | 2019年 / 75卷 / 822-832期
关键词
polymorphic modifications; crystal structure; concomitant crystallization; pairwise interaction energy; 1-benzopyran-2-one; SUPRAMOLECULAR ARCHITECTURE; COUMARIN DERIVATIVES; DESIGN; INHIBITORS; CRYSTALS;
D O I
10.1107/S2053229619006405
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The polymorphic study of 3-(3-phenyl-1H-1,2,4-triazol-5-yl)-2H-1-benzopyran-2-one, C17H11N3O2, was performed due to its potential biological activity and revealed three polymorphic modifications in the triclinic space group P (1) over bar, the monoclinic space group P2(1) and the orthorhombic space group Pbca. These polymorphs have a one-column layered type of crystal organization. The strongest interactions between the molecules of the studied structures is stacking between pi-systems, while N-H center dot center dot center dot N and C-H center dot center dot center dot O hydrogen bonds link stacked columns forming layers as a secondary basic structural motif. C-H center dot center dot center dot pi hydrogen bonds were observed between neighbouring layers and their role is the least significant in the formation of the crystal structure. Packing differences between the polymorphic modifications are minor and can be identified only using an analysis based on a comparison of the pairwise interaction energies.
引用
收藏
页码:822 / +
页数:29
相关论文
共 50 条
[1]  
[Anonymous], 2010, ORCA VERSION 2 8 0
[2]  
[Anonymous], 2006, POLYMORPHISM PHARM I
[3]  
Bader R. F. W., 1990, ATOMS MOL
[4]   Polymorphism - A Perspective [J].
Bernstein, Joel .
CRYSTAL GROWTH & DESIGN, 2011, 11 (03) :632-650
[5]   Structural distortion of the α, β, and γ polymorphs of glycine on cooling [J].
Boldyreva, EV ;
Drebushchak, TN ;
Shutova, ES .
ZEITSCHRIFT FUR KRISTALLOGRAPHIE, 2003, 218 (05) :366-376
[6]   Simple coumarins and analogues in medicinal chemistry: Occurrence, synthesis and biological activity [J].
Borges, F ;
Roleira, F ;
Milhazes, N ;
Santana, L ;
Uriarte, E .
CURRENT MEDICINAL CHEMISTRY, 2005, 12 (08) :887-916
[7]   CALCULATION OF SMALL MOLECULAR INTERACTIONS BY DIFFERENCES OF SEPARATE TOTAL ENERGIES - SOME PROCEDURES WITH REDUCED ERRORS [J].
BOYS, SF ;
BERNARDI, F .
MOLECULAR PHYSICS, 1970, 19 (04) :553-&
[8]  
Brittain H.G., 1999, POLYMORPHISM PHARM S
[9]   New arylpyrazoline-coumarins: Synthesis and anti-inflammatory activity [J].
Chen, Liu Zeng ;
Sun, Wei Wei ;
Bo, Li ;
Wang, Jie Quan ;
Xiu, Cheng ;
Tang, Wen Jian ;
Shi, Jing Bo ;
Zhou, Hai Pin ;
Liu, Xin Hua .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 138 :170-181
[10]   Novel dihydropyrazole-chromen: Design and modulates hTERT inhibition proliferation of MGC-803 [J].
Chen, Yan Yan ;
Wu, Xiao Qin ;
Tang, Wen Jian ;
Shi, Jing Bo ;
Li, Jun ;
Liu, Xin Hua .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 110 :65-75